RedHill Biopharma Ltd.
Formulations and methods of manufacturing formulations for use in colonic evacuation
Last updated:
Abstract:
Formulations and methods of manufacturing formulations for use in colonic evacuation are disclosed herein, in an embodiment, a solid dosage formulation includes an intra-granular fraction intermingled with an extra-granular fraction, wherein the intra-granular fraction includes granules comprising at least one osmotic evacuant agent, at least one antacid, and a first pharmaceutically acceptable excipient component, and wherein the extra-granular fraction includes one or more organic acids, a non-metallic lubricating element, and a second pharmaceutically acceptable excipient component.
Status:
Grant
Type:
Utility
Filling date:
25 Oct 2019
Issue date:
13 Jul 2021